Alkermes
CompanyIrelandFounded 1987
Alkermes develops one asset, in phase 2 (LYBALVI in alcohol use disorder). Mostly small molecule acting on HTR2A, DRD2 and OPRM1; based in Ireland, founded in 1987.
- 1
- Asset
- Furthest
- Phase 2
- 9
- Trials
- 0
- Signals
Pipeline
1Combination of olanzapine with samidorphan, an opioid receptor antagonist to mitigate weight gain
Phase 2, Small molecule, HTR2A, DRD2, alcohol use disorder, schizophrenia
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Evidence behind the mechanisms3
- Trials17
- Similar companies6
Updated 11 Oct 2026 · 26 sources